ArticleJournal of family medicine and primary care2025
Association of neutrophil-to-lymphocyte ratio and CRP with spirometry in COPD patients in North India.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between Neutrophil to Lymphocyte Ratio/Serum Albumin Ratio and Chronic Obstructive Pulmonary Disease: Results from NHANES 1999-2018.International journal of chronic obstructive pulmonary disease · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) who have high serum levels of C-reactive protein (CRP), a marker of low-grade systemic inflammation, exhibit reduced lung functions and a worse prognosis. The neutrophil-to-lymphocyte ratio (N/L ratio, NLR), obtained from a complete blood count, is an inexpensive and easily accessible inflammation marker. The NLR has proven useful in assessing the risk for patients with various cardiovascular conditions, different types of solid tumours, sepsis, and infectious diseases. Research indicates that COPD patients have significantly higher NLR values compared to healthy controls of the same age and sex, with these values increasing even more during acute COPD exacerbations compared to stable periods. Hence, identifying non-invasive and cost-effective tools to assess the severity of COPD in the PHC/CHC level would be beneficial as an early intervention. Aim: To study the relationship between N/L ratio and CRP levels and spirometry in COPD patients. Settings and Study Design: Observational cross-sectional study. Methods and Material: A total of 100 patients of an age > 40 years with a confirmed diagnosis of COPD according to GOLD (Global Initiative COPD patients) criteria were selected. With an informed consent, blood sample collection for N/L ratio and CRP along with spirometry was performed in all the patients. Statistical Analysis Used: SPSS software with Student t-test, Chi-square t-test, ANOVA, and Spearman correlation with 95% CI is used. Results: NLR was observed to be higher in the moderate grade of COPD patients. All the patients were observed with an abnormal (>5 mg/L) CRP level. FEV1, FVC%, FEV1/FVC%, N/L ratio, and CRP were significantly ( Conclusions: This study concludes that the FEV1, FVC, and FEV1/FVC ratio were lower in severe COPD patients, and it also reveals that individuals with severe COPD have elevated levels of serum CRP and N/L ratio, which correlates with the severity of COPD. Elevated N/L ratio and CRP level may be used as non invasive predictors and cost-effective tools for COPD patients at the Primary health centre level for screening of the severity of COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.